Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision 3.5.0 was added to the revision history, and Revision 3.4.3 was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior government funding/status notices; the revision history is updated accordingly.SummaryDifference0.1%

- Check62 days agoChange DetectedSite-wide notice about a lapse in government funding appears and the page shows Revision: v3.4.1; there are no changes to the study's core content, outcomes, or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded a glossary display option and updated revision metadata to v3.4.0, including a No FEAR Act Data notice. Removed the previous QC update label (Last Update Submitted that met QC Criteria), the older No FEAR Act data text, and the prior revision indicator (v3.3.4).SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.